Literature DB >> 23149716

Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase for use in cDNA synthesis.

Atsushi Konishi1, Mayu Shinomura, Kiyoshi Yasukawa.   

Abstract

The aim of this study is to explore the advantages of using human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) in cDNA synthesis. Recombinant HIV-1 group M (HIV-1 M) RT and HIV-1 group O (HIV-1 O) RT were produced in an Escherichia coli expression system. In the incorporation of dTTP into poly(rA)-p(dT)(15) (T/P), the K (m) values for dTTP of HIV-1 M RT and HIV-1 O RT were 8 and 12 % of that of Moloney murine leukemia virus (MMLV) RT, respectively, and the K (m) values for T/P were 25 and 23 % of that of MMLV RT, respectively. Compared with MMLV RT, HIV-1 M RT and HIV-1 O RT were less susceptible to formamide, which is frequently used for cDNA synthesis with a G + C-rich RNA to improve specificity. The high substrate affinity and low susceptibility to formamide of HIV-1 RT might be advantageous for its use in cDNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149716     DOI: 10.1007/s12010-012-9953-8

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  2 in total

1.  Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.

Authors:  Tetsuro Hisayoshi; Mayu Shinomura; Kanta Yokokawa; Ikumi Kuze; Atsushi Konishi; Kumi Kawaji; Eiichi N Kodama; Keishi Hata; Saori Takahashi; Satoru Nirasawa; Shohei Sakuda; Kiyoshi Yasukawa
Journal:  J Nat Med       Date:  2015-02-08       Impact factor: 2.343

2.  Enzymatic Activities of RNase H Domains of HIV-1 Reverse Transcriptase with Substrate Binding Domains of Bacterial RNases H1 and H2.

Authors:  Etin-Diah Permanasari; Kiyoshi Yasukawa; Shigenori Kanaya
Journal:  Mol Biotechnol       Date:  2015-06       Impact factor: 2.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.